| Product Code: ETC7745576 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Phosphodiesterase (PDE) Inhibitors Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Phosphodiesterase (PDE) Inhibitors Market - Industry Life Cycle |
3.4 Japan Phosphodiesterase (PDE) Inhibitors Market - Porter's Five Forces |
3.5 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Phosphodiesterase (PDE) Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of erectile dysfunction in Japan |
4.2.2 Growing awareness about the benefits of phosphodiesterase (PDE) inhibitors |
4.2.3 Technological advancements leading to the development of more effective PDE inhibitors |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new PDE inhibitors in Japan |
4.3.2 Presence of alternative treatments for erectile dysfunction |
4.3.3 Potential side effects associated with PDE inhibitors impacting consumer confidence |
5 Japan Phosphodiesterase (PDE) Inhibitors Market Trends |
6 Japan Phosphodiesterase (PDE) Inhibitors Market, By Types |
6.1 Japan Phosphodiesterase (PDE) Inhibitors Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Specific, 2021- 2031F |
6.1.4 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Non-Specific, 2021- 2031F |
6.1.5 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Phosphodiesterase (PDE) Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Congestive Heart Failure, 2021- 2031F |
6.2.3 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Erectile Dysfunction, 2021- 2031F |
6.2.4 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Inflammatory Airways Disease, 2021- 2031F |
6.2.5 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Phosphodiesterase (PDE) Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Phosphodiesterase (PDE) Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Japan Phosphodiesterase (PDE) Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Japan Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Japan Phosphodiesterase (PDE) Inhibitors Market Import-Export Trade Statistics |
7.1 Japan Phosphodiesterase (PDE) Inhibitors Market Export to Major Countries |
7.2 Japan Phosphodiesterase (PDE) Inhibitors Market Imports from Major Countries |
8 Japan Phosphodiesterase (PDE) Inhibitors Market Key Performance Indicators |
8.1 Number of new PDE inhibitors approved for sale in Japan |
8.2 Patient adherence rates to PDE inhibitor therapies |
8.3 Rate of prescriptions for PDE inhibitors compared to other erectile dysfunction treatments |
9 Japan Phosphodiesterase (PDE) Inhibitors Market - Opportunity Assessment |
9.1 Japan Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Japan Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Japan Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Japan Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Japan Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Phosphodiesterase (PDE) Inhibitors Market - Competitive Landscape |
10.1 Japan Phosphodiesterase (PDE) Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Japan Phosphodiesterase (PDE) Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here